Report cover image

Cancer Nutrition Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 128 Pages
SKU # APRC20261506

Description

Summary

According to APO Research, the global Cancer Nutrition market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Cancer Nutrition is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cancer Nutrition is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Cancer Nutrition is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Cancer Nutrition include Abbott Laboratories, Nestlé Health Science, Nestlé, Baxter, Nutricia, Medtrition, Inc, Hormel Foods Corporation (Hormel Health Labs), Hormel Foods Corporation and Fresubin, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cancer Nutrition, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Nutrition.

The report will help the Cancer Nutrition manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.



The Cancer Nutrition market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Nutrition market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Cancer Nutrition Segment by Company

Abbott Laboratories
Nestlé Health Science
Nestlé
Baxter
Nutricia
Medtrition, Inc
Hormel Foods Corporation (Hormel Health Labs)
Hormel Foods Corporation
Fresubin
Fresenius Kabi AG
Filtricine
Esperer Onco Nutrition
Danone
B. Braun SE
Cancer Nutrition Segment by Type

Enteral Nutrition
Parenteral Nutrition
Cancer Nutrition Segment by Application

Hospitals
Cancer Centers
Home Care
Cancer Nutrition Segment by Region


North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Nutrition market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cancer Nutrition and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Nutrition.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cancer Nutrition manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cancer Nutrition by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cancer Nutrition in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

128 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Cancer Nutrition Market Size (2020-2031)
2.2.2 Global Cancer Nutrition Sales (2020-2031)
2.2.3 Global Cancer Nutrition Market Average Price (2020-2031)
2.3 Cancer Nutrition by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Enteral Nutrition
2.3.3 Parenteral Nutrition
2.4 Cancer Nutrition by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospitals
2.4.3 Cancer Centers
2.4.4 Home Care
3 Market Competitive Landscape by Manufacturers
3.1 Global Cancer Nutrition Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Cancer Nutrition Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Cancer Nutrition Revenue of Manufacturers (2020-2025)
3.4 Global Cancer Nutrition Average Price by Manufacturers (2020-2025)
3.5 Global Cancer Nutrition Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Cancer Nutrition, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Cancer Nutrition, Product Type & Application
3.8 Global Manufacturers of Cancer Nutrition, Established Date
3.9 Global Cancer Nutrition Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Abbott Laboratories
4.1.1 Abbott Laboratories Company Information
4.1.2 Abbott Laboratories Business Overview
4.1.3 Abbott Laboratories Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Abbott Laboratories Cancer Nutrition Product Portfolio
4.1.5 Abbott Laboratories Recent Developments
4.2 Nestlé Health Science
4.2.1 Nestlé Health Science Company Information
4.2.2 Nestlé Health Science Business Overview
4.2.3 Nestlé Health Science Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Nestlé Health Science Cancer Nutrition Product Portfolio
4.2.5 Nestlé Health Science Recent Developments
4.3 Nestlé
4.3.1 Nestlé Company Information
4.3.2 Nestlé Business Overview
4.3.3 Nestlé Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Nestlé Cancer Nutrition Product Portfolio
4.3.5 Nestlé Recent Developments
4.4 Baxter
4.4.1 Baxter Company Information
4.4.2 Baxter Business Overview
4.4.3 Baxter Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Baxter Cancer Nutrition Product Portfolio
4.4.5 Baxter Recent Developments
4.5 Nutricia
4.5.1 Nutricia Company Information
4.5.2 Nutricia Business Overview
4.5.3 Nutricia Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Nutricia Cancer Nutrition Product Portfolio
4.5.5 Nutricia Recent Developments
4.6 Medtrition, Inc
4.6.1 Medtrition, Inc Company Information
4.6.2 Medtrition, Inc Business Overview
4.6.3 Medtrition, Inc Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Medtrition, Inc Cancer Nutrition Product Portfolio
4.6.5 Medtrition, Inc Recent Developments
4.7 Hormel Foods Corporation (Hormel Health Labs)
4.7.1 Hormel Foods Corporation (Hormel Health Labs) Company Information
4.7.2 Hormel Foods Corporation (Hormel Health Labs) Business Overview
4.7.3 Hormel Foods Corporation (Hormel Health Labs) Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Hormel Foods Corporation (Hormel Health Labs) Cancer Nutrition Product Portfolio
4.7.5 Hormel Foods Corporation (Hormel Health Labs) Recent Developments
4.8 Hormel Foods Corporation
4.8.1 Hormel Foods Corporation Company Information
4.8.2 Hormel Foods Corporation Business Overview
4.8.3 Hormel Foods Corporation Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Hormel Foods Corporation Cancer Nutrition Product Portfolio
4.8.5 Hormel Foods Corporation Recent Developments
4.9 Fresubin
4.9.1 Fresubin Company Information
4.9.2 Fresubin Business Overview
4.9.3 Fresubin Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Fresubin Cancer Nutrition Product Portfolio
4.9.5 Fresubin Recent Developments
4.10 Fresenius Kabi AG
4.10.1 Fresenius Kabi AG Company Information
4.10.2 Fresenius Kabi AG Business Overview
4.10.3 Fresenius Kabi AG Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Fresenius Kabi AG Cancer Nutrition Product Portfolio
4.10.5 Fresenius Kabi AG Recent Developments
4.11 Filtricine
4.11.1 Filtricine Company Information
4.11.2 Filtricine Business Overview
4.11.3 Filtricine Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Filtricine Cancer Nutrition Product Portfolio
4.11.5 Filtricine Recent Developments
4.12 Esperer Onco Nutrition
4.12.1 Esperer Onco Nutrition Company Information
4.12.2 Esperer Onco Nutrition Business Overview
4.12.3 Esperer Onco Nutrition Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Esperer Onco Nutrition Cancer Nutrition Product Portfolio
4.12.5 Esperer Onco Nutrition Recent Developments
4.13 Danone
4.13.1 Danone Company Information
4.13.2 Danone Business Overview
4.13.3 Danone Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Danone Cancer Nutrition Product Portfolio
4.13.5 Danone Recent Developments
4.14 B. Braun SE
4.14.1 B. Braun SE Company Information
4.14.2 B. Braun SE Business Overview
4.14.3 B. Braun SE Cancer Nutrition Sales, Revenue and Gross Margin (2020-2025)
4.14.4 B. Braun SE Cancer Nutrition Product Portfolio
4.14.5 B. Braun SE Recent Developments
5 Global Cancer Nutrition Market Scenario by Region
5.1 Global Cancer Nutrition Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Cancer Nutrition Sales by Region: 2020-2031
5.2.1 Global Cancer Nutrition Sales by Region: 2020-2025
5.2.2 Global Cancer Nutrition Sales by Region: 2026-2031
5.3 Global Cancer Nutrition Revenue by Region: 2020-2031
5.3.1 Global Cancer Nutrition Revenue by Region: 2020-2025
5.3.2 Global Cancer Nutrition Revenue by Region: 2026-2031
5.4 North America Cancer Nutrition Market Facts & Figures by Country
5.4.1 North America Cancer Nutrition Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Cancer Nutrition Sales by Country (2020-2031)
5.4.3 North America Cancer Nutrition Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Cancer Nutrition Market Facts & Figures by Country
5.5.1 Europe Cancer Nutrition Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Cancer Nutrition Sales by Country (2020-2031)
5.5.3 Europe Cancer Nutrition Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Cancer Nutrition Market Facts & Figures by Country
5.6.1 Asia Pacific Cancer Nutrition Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Cancer Nutrition Sales by Country (2020-2031)
5.6.3 Asia Pacific Cancer Nutrition Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Cancer Nutrition Market Facts & Figures by Country
5.7.1 South America Cancer Nutrition Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Cancer Nutrition Sales by Country (2020-2031)
5.7.3 South America Cancer Nutrition Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Cancer Nutrition Market Facts & Figures by Country
5.8.1 Middle East and Africa Cancer Nutrition Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Cancer Nutrition Sales by Country (2020-2031)
5.8.3 Middle East and Africa Cancer Nutrition Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Cancer Nutrition Sales by Type (2020-2031)
6.1.1 Global Cancer Nutrition Sales by Type (2020-2031) & (K Units)
6.1.2 Global Cancer Nutrition Sales Market Share by Type (2020-2031)
6.2 Global Cancer Nutrition Revenue by Type (2020-2031)
6.2.1 Global Cancer Nutrition Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Cancer Nutrition Revenue Market Share by Type (2020-2031)
6.3 Global Cancer Nutrition Price by Type (2020-2031)
7 Segment by Application
7.1 Global Cancer Nutrition Sales by Application (2020-2031)
7.1.1 Global Cancer Nutrition Sales by Application (2020-2031) & (K Units)
7.1.2 Global Cancer Nutrition Sales Market Share by Application (2020-2031)
7.2 Global Cancer Nutrition Revenue by Application (2020-2031)
7.2.1 Global Cancer Nutrition Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Cancer Nutrition Revenue Market Share by Application (2020-2031)
7.3 Global Cancer Nutrition Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Cancer Nutrition Value Chain Analysis
8.1.1 Cancer Nutrition Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Cancer Nutrition Production Mode & Process
8.2 Cancer Nutrition Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Cancer Nutrition Distributors
8.2.3 Cancer Nutrition Customers
9 Global Cancer Nutrition Analyzing Market Dynamics
9.1 Cancer Nutrition Industry Trends
9.2 Cancer Nutrition Industry Drivers
9.3 Cancer Nutrition Industry Opportunities and Challenges
9.4 Cancer Nutrition Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.